3D bioprinting is a process to produce tissues in a variety of formats
from micro-scale tissues to standard multi-well tissues, where cell function
and viability are preserved within the printed construct. A 3D bioprinter is a
medical device used to regenerate human tissues, which are created by human
cells. The 3D micro-engineered environments open new ¬channels for drug
screening and fundamental studies of wound healing, angiogenesis, and stem-cell
niches. Many industries have already benefitted from multiple advancements in
this field, resulting in improved and more efficient processes worldwide.
Analysts forecast the Global 3D Bioprinting
market to grow at a CAGR of 14.52 percent over the period
2013-2018.
Covered in this
Report
The Global 3D Bioprinting market can be segmented into the technology
available in the market: Ink-jet Bioprinters, Valve-based Cell Printers,
Laser-assisted Cell Printers, and Magnetic Levitation Bioprinters.
Global 3D Bioprinting Market 2014-2018, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers
the Americas, and the APAC and EMEA regions; it also covers the Global 3D
Bioprinting market landscape and its growth prospects in the coming years. The
report also includes a discussion of the key vendors operating in this market.
Single User License of the Report is Available
at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=22927 .
Key Regions
- Americas
- APAC
- EMEA
Key Vendors
- 3D Systems
- EnvisionTEC
- Organovo Holdings
- Stratasys
Prominent Vendors
- 3D Biotek
- Advanced Biomatrix
- Bespoke Innovations
- Digilab
- regenHU
- Nano3D Biosciences
